Vitality Watch

Dossier pubmed review 19-aug-2026
Narrative review or expert overview without new data

A minimal three-arm oral regimen for healthspan: mechanistic alignment with transcriptomic signals from a large parental-lifespan GWAS.

Key claim: A minimal three-arm oral regimen—exploratory glutamatergic agents, NMN plus NAC with pulsed senolytics, and GLP-1 agonism—is proposed to align with transcriptomic programs linked to longer genetically predicted parental lifespan.

Abstract

A large genome-wide association study of parental lifespan was reported in 2019. A later transcriptome-wide association study (TWAS) based on those summary statistics identified a set of transcriptional programs associated with longer genetically predicted survival, including increased brain NAD + salvage, especially NMNAT2, reduced glucose-stimulated insulin secretion, a shift toward synaptic pruning with less broad plasticity, and a glial pattern characterized by relatively greater microglial and lower astrocytic signatures, with only weak pan-tissue senescence signals. Building on those directional findings, this short communication proposes a minimal three-arm oral regimen with unequal evidentiary weight: first, the Cheung Glutamatergic Regimen, consisting of low-dose dextromethorphan potentiated by a CYP2D6 inhibitor together with piracetam and L-glutamine, as an exploratory adjunct aimed at preserving residual functional connectivity; second, daily nicotinamide mononucleotide and N-acetylcysteine with pulsed senolytics for NAD + salvage and senescence modulation; and third, GLP-1 receptor agonism for metabolic reprogramming. The NAD+/senescence arm is the primary mechanistic anchor, GLP-1 receptor agonism provides secondary metabolic support, and the glutamatergic arm is exploratory. Each arm targets a separate node within the pruning-plasticity-metabolic triad. The regimen is fully oral, uses conservative dosing, and draws on prior therapeutic or human-exposure data, although the proposed combination has no established safety profile. Although direct combination data are lacking and the foundational TWAS remains a preprint, the components show plausible but uneven mechanistic alignment with the TWAS signals and may justify carefully designed, safety-focused pilot evaluation.

Why this matters

A minimal three-arm oral regimen—exploratory glutamatergic agents, NMN plus NAC with pulsed senolytics, and GLP-1 agonism—is proposed to align with transcriptomic programs linked to longer genetically predicted parental lifespan.

Source

Link

Briefing card

A minimal three-arm oral regimen for healthspan: mechanistic alignment with transcriptomic signals from a large parental-lifespan GWAS.
Stage: review · pubmed · 19-aug-2026

A minimal three-arm oral regimen—exploratory glutamatergic agents, NMN plus NAC with pulsed senolytics, and GLP-1 agonism—is proposed to align with transcriptomic programs linked to longer genetically predicted parental lifespan.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.3389/fragi.2026.1856979

build build 880 · 2bcef25 · 2026-11-18